PuSH - Publikationsserver des Helmholtz Zentrums München

Barahona Ponce, C.* ; Scherer, D.* ; Brinster, R.* ; Boekstegers, F.* ; Marcelain, K.* ; Gárate, V.* ; Müller, B.* ; de Toro, G.* ; Retamales, J.* ; Barajas, O.* ; Ahumada, M.* ; Morales, E.* ; Rojas, A.* ; Sanhueza, V.* ; Loader, D.* ; Rivera, M.T.* ; Gutiérrez, L.* ; Bernal, G.* ; Ortega, A.* ; Montalvo, D.* ; Portiño, S.* ; Bertrán, M.E.* ; Gabler, F.* ; Spencer, L.* ; Olloquequi, J.* ; Fischer, C.* ; Jenab, M.* ; Aleksandrova, K.* ; Katzke, V.* ; Weiderpass, E.* ; Bonet, C.* ; Moradi, T.* ; Fischer, K.* ; Bossers, W.* ; Brenner, H.* ; Hveem, K.* ; Eklund, N.* ; Völker, U.* ; Waldenberger, M. ; Fuentes Guajardo, M. ; Gonzalez-Jose, R.* ; Bedoya, G.* ; Bortolini, M.C.* ; Canizales, S.* ; Gallo, C.* ; Ruiz Linares, A.* ; Rothhammer, F. ; Lorenzo Bermejo, J.*

Gallstones, body mass index, C-reactive protein and gallbladder cancer—Mendelian randomization analysis of chilean and European genotype data.

Hepatology 73, 1783-1796 (2021)
Verlagsversion Postprint DOI PMC
Open Access Hybrid
BACKGROUND & AIMS: Gallbladder cancer (GBC) is a neglected disease with substantial geographical variability: Chile shows the highest incidence worldwide, while GBC is relatively rare in Europe. Here we investigate the causal effects of risk factors considered in current GBC prevention programmes as well as C-reactive protein (CRP) level as a marker of chronic inflammation. APPROACH & RESULTS: We applied two-sample Mendelian randomization (MR) using publicly available data and our own data from a retrospective Chilean and a prospective European study. Causality was assessed by inverse variance weighted (IVW), MR-Egger regression and weighted median estimates complemented with sensitivity analyses on potential heterogeneity and pleiotropy, two-step MR and mediation analysis. We found evidence for a causal effect of gallstone disease on GBC risk in Chileans (p = 9 × 10-5 ) and Europeans (p = 9 × 10-5 ). A genetically elevated body mass index (BMI) increased GBC risk in Chileans (p = 0.03), while higher CRP concentrations increased GBC risk in Europeans (p = 4.1 × 10-6 ). European results suggest causal effects of BMI on gallstone disease (p = 0.008); public Chilean data were not, however, available to enable assessment of the mediation effects among causal GBC risk factors. CONCLUSIONS: Two risk factors considered in the current Chilean programme for GBC prevention are causally linked to GBC risk: gallstones and BMI. For Europeans, BMI showed a causal effect on gallstone risk, which was itself causally linked to GBC risk.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
17.425
2.762
1
7
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter C-reactive Protein ; Gallbladder Cancer ; Gallstones ; Mendelian Randomization ; Native American Ancestry; Reproductive Factors; Genetic-variants; Risk-factors; Life-style; Disease; Association; Adiposity; Weight; Susceptibility; Inflammation
Sprache englisch
Veröffentlichungsjahr 2021
Prepublished im Jahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 0270-9139
e-ISSN 1527-3350
Zeitschrift Hepatology
Quellenangaben Band: 73, Heft: 5, Seiten: 1783-1796 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort Hoboken, NJ
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology (EPI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-504091-001
Förderungen Heidelberg University
Deutsche Forschungsgemeinschaft Universitaet Heidelberg - Programme Open Access Publishing
Bundesministerium für Bildung und Forschung
UK Biobank Resource
Biobanking and Biomolecular Research Infrastructure - Large Prospective Cohorts
H2020 European Research CouncilH2020 European Research Council
Scopus ID 85104970954
PubMed ID 32893372
Erfassungsdatum 2021-02-08